Does TRAMETINIB Cause Immune-mediated hepatitis? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Immune-mediated hepatitis have been filed in association with TRAMETINIB. This represents 0.2% of all adverse event reports for TRAMETINIB.
12
Reports of Immune-mediated hepatitis with TRAMETINIB
0.2%
of all TRAMETINIB reports
1
Deaths
9
Hospitalizations
How Dangerous Is Immune-mediated hepatitis From TRAMETINIB?
Of the 12 reports, 1 (8.3%) resulted in death, 9 (75.0%) required hospitalization, and 1 (8.3%) were considered life-threatening.
Is Immune-mediated hepatitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRAMETINIB. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does TRAMETINIB Cause?
Pyrexia (1,096)
Malignant neoplasm progression (807)
Product use in unapproved indication (349)
Diarrhoea (325)
Nausea (301)
Rash (290)
Vomiting (289)
Fatigue (269)
Death (240)
Chills (227)
What Other Drugs Cause Immune-mediated hepatitis?
NIVOLUMAB (640)
PEMBROLIZUMAB (549)
IPILIMUMAB (443)
CARBOPLATIN (213)
PACLITAXEL (167)
ATEZOLIZUMAB (142)
BEVACIZUMAB (108)
DURVALUMAB (90)
LENVATINIB (86)
PEMETREXED (86)
Which TRAMETINIB Alternatives Have Lower Immune-mediated hepatitis Risk?
TRAMETINIB vs TRAMETINIB DIMETHYL SULFOXIDE
TRAMETINIB vs TRANDOLAPRIL
TRAMETINIB vs TRANDOLAPRIL\VERAPAMIL
TRAMETINIB vs TRANEXAMIC ACID
TRAMETINIB vs TRANYLCYPROMINE